Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02446548Completed
Randomised, double-blind trial of aliskiren in albuminuria (2 arms), sponsored by Medical University of Gdańsk. Primary endpoint: Difference in albuminuria at 8 weeks. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02446548.